Image Ben Hargreaves Digital AI is enabling the rise of sophisticated digital therapeutic... Ben Hargreaves explores the capability of AI and machine learning to produce ever more accurate and effective digital therapeutics. Market Access Is pharma market on the rebound in 2023? As the financial markets have been roiled by inflation and a minor banking crisis, the pharma industry experienced a period where M&A largely disappeared and investment into biotechs dr Sales & Marketing The drug pricing discussion that won’t disappear Discussions of the pharma industry in the political sphere have lingered on pricing for a number of years. R&D Manufacturing key to overcoming the next pandemic Ben Hargreaves looks at the way governments are preparing for a future pandemic. Load more results
Digital AI is enabling the rise of sophisticated digital therapeutic... Ben Hargreaves explores the capability of AI and machine learning to produce ever more accurate and effective digital therapeutics.
Market Access Is pharma market on the rebound in 2023? As the financial markets have been roiled by inflation and a minor banking crisis, the pharma industry experienced a period where M&A largely disappeared and investment into biotechs dr
Sales & Marketing The drug pricing discussion that won’t disappear Discussions of the pharma industry in the political sphere have lingered on pricing for a number of years.
R&D Manufacturing key to overcoming the next pandemic Ben Hargreaves looks at the way governments are preparing for a future pandemic.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.